Relationship between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function

Hypertension

Volumn 43, Issue 2 I, 2004, Pages 186-191

  Summar, Marshall L ^a   Gainer, James V ^a   Pretorius, Mias ^a   Malave, Hector ^a   Harris, Stephanie ^a   Hall, Lynn D ^a   Weisberg, Alec ^a   Vaughan, Douglas E ^a   Christman, Brian W ^a   Brown, Nancy J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bradykinin; Endothelium; Genetics; Nitric oxide; Vasodilation

Indexed keywords

ARGININE; BRADYKININ; CARBAMOYL PHOSPHATE SYNTHASE; CITRULLINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR SYSTEM; CATALYSIS; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIUM CELL; FEMALE; FOREARM BLOOD FLOW; GENETIC CODE; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPOTHESIS; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION; SMOOTH MUSCLE; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

ADULT; ARGININE; BRADYKININ; CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA); CITRULLINE; FEMALE; FOREARM; GENOTYPE; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; POLYMORPHISM, GENETIC; REGIONAL BLOOD FLOW; UREA; VASODILATION; VASODILATOR AGENTS;

EID: 10744225397     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000112424.06921.52     Document Type: Article

References (25)

1. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
2. Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res. 2002;55:250-260.
3. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
4. Panza JA, Quyyumi AA, Brush JE, Jr, Epstein S. E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
5. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 1991;338:1546-1550.
6. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248-1253.
7. Clarkson P, Adams MR, Powe AJ, Donald AE, McCredie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 1996;97:1989-1994.
8. Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci U S A. 1990;87:8612-8616.
9. Wu G, Meininger CJ. Regulation of L-arginine synthesis from L-citrulline by L-glutamine in endothelial cells. Am J Physiol. 1993;265: H1965-H1971.
10. Morris SM, Jr. Regulation of enzymes of the urea cycle and arginine metabolism. Anna Rev Nutr. 2002;22:87-105.
11. Summar ML, Hall LD, Eeds AM, Hutcheson HB, Kuo AN, Willis AS, Rubio V, Arvin MK, Schofield JP, Dawson EP. Characterization of genomic structure and polymorphisms in the human carbamyl phosphate synthetase 1 gene. Gene. 2003;311:51-57.
12. Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med. 2001;344:1832-1838.
13. 2 receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation. 2000;102:2190-2196.
14. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation. 1999;99:1411-1415.
15. Fleming I, Busse R. Signal transduction of eNOS activation. Cardiovasc Res. 1999;43:532-541.
16. Ruiz E, Tejerina T. Relaxant effects of L-citrulline in rabbit vascular smooth muscle. Br J Pharmacol. 1998;125:186-192.
17. Featherston WR, Rogers QR, Freedland RA. Relative importance of kidney and liver in synthesis of arginine by the rat. Am J Physiol. 1973;224:127-129.
18. Mair J, Puschendorf B. Is measurement of cyclic guanosine monophosphate in plasma or urine suitable for assessing in vivo nitric oxide production? Circulation. 1998;97:1209-1210.
19. Green LC, Ruiz dL, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR. Nitrate biosynthesis in man. Proc Natl Acad Sci U S A. 1981;78:7764-7768.
20. Lepage N, McDonald N, Dallaire L, Lambert M. Age-specific distribution of plasma amino acid concentrations in a healthy pediatric population. Clin Chem. 1997;43:2397-2402.
21. Cardillo C, Kilcoyne CM, Cannon RO, Panza JA. Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation. 1999;99:90-95.
22. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, Wood M, Wood AJJ. Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med. 1995;333:155-160.
23. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190-193.
24. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001;11:719-725.
25. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-2678.